Global Considerations for Oligonucleotide Synthesis Solutions

The webinar will address considerations when evaluating oligonucleotide synthesis reagent and solvent suppliers. Topics include scaling production during a global crisis; accessing manufacturing resources on multiple continents; and transitioning from glass to returnable containers to save space, cost, and time, while being environmentally conscious.

Register Free: https://www.pharmtech.com/pt_w/oligonucleotide-synthesis-solutions

Event Overview:

Join us for an in-depth webinar that will explore what global contract development and manufacturing organizations (CDMOs) and commercial life science pharmaceutical organizations in the oligonucleotide synthesis space look for when evaluating primary and secondary suppliers of high-purity reagents and solvents in light of the recent pandemic. This webinar provides an overview of the key considerations for supporting oligonucleotide synthesis across various contexts, with a special focus on the latest advancements in sulfurization reagents and water determination techniques.

Key Learning Objectives:

• Why a global manufacturing footprint is as critical as having batch-to-batch consistency.
• What to look for when evaluating suppliers to produce custom blends of reagents and solvents in varying batch sizes.
• What can be gained by transitioning your solvents and reagents from glass to returnable containers.
• Is access to a regional expert adequate when scaling to production during a global crisis?
• What are the challenges associated with sulfurization reagents for oligonucleotide synthesis and what’s the risk of limited access to technical experts?

Who Should Attend:
This webinar is ideal for professionals involved in oligonucleotide synthesis, including researchers, laboratory managers, and product development specialists, who are looking to enhance the stability and efficiency of their oligo synthesis processes and supply chain. This webinar is open to professionals with roles supporting:

• Oligonucleotide synthesis CDMOs
• Diagnostic and therapeutic manufacturers
• Commercial life sciences organizations
• Organizations that perform or require solvents and reagents for:
  • Biotech/pharmaceutical manufacturing
  • DNA/RNA sequencing
  • DNA/RNA purification
  • DNA/RNA synthesis
  • Peptide synthesis

Speakers:

Stefan Seekamp, PhD
R&D Manager, Research Chemicals
Honeywell

Stefan Seekamp, PhD, studied chemistry at the Leibniz University Hannover in Hanover, Germany, with a focus on analytical chemistry. Dr Seekamp completed his dissertation on the topic of method development for low-intermediate radioactive waste at the Jülich Research Centre in Jülich, Germany. He held a postdoctoral position at the Argonne National Laboratory in Lemont, Illinois, in the United States. Dr Seekamp has held a wide range of positions with Honeywell since 2002 and is currently the global R&D leader for Honeywell Research Chemicals.

Marc Lorain
Director, Strategic Accounts Management
Honeywell

Marc Lorain studied biology at the Lyon I University with a focus on agronomy.
Lorain began his career as a sales representative for a regional distributor in France and then held sales management positions for leading international chemical and biological reagent companies. He joined Honeywell in 2016 as the global sales leader for research chemicals. Currently, he is director of strategic accounts management and oversees the life sciences and pharmaceutical markets for EMEA.

Register Free: https://www.pharmtech.com/pt_w/oligonucleotide-synthesis-solutions